Controversy Surrounding Indonesia's Tobacco and E-Cigarette Regulation Draft

Sep.19.2024
Controversy Surrounding Indonesia's Tobacco and E-Cigarette Regulation Draft
Indonesia's Health Ministry is asked to suspend discussions on tobacco and e-cigarette safety regulations, sparking industry concerns.

According to a report from Metrotv News on September 18, the Indonesian Ministry of Health has been asked to suspend discussions on the draft of the 2024 Tobacco and E-cigarette Product Safety Regulation (RPMK). The regulation has been criticized for restricting the market space for tobacco and e-cigarette products, and potentially harming Indonesia's tobacco farming and tobacco industry chain.


According to reports, this suggestion was put forward during a national dialogue event held at the Ashley Hotel in Jakarta on September 17 by pesantren and the Community Development Center (P3M).


The event was attended by a total of 50 representatives from government agencies, farmers' associations, trade unions, retailers associations, businesses, tobacco industry associations, civil society alliances, academia, religious leaders, and media. P3M Director Sarmidi Husna expressed concerns about the RPMK 2024 draft primarily due to its proposed plain packaging regulations, which are seen as restrictive to the tobacco industry. Husna noted that there was insufficient public participation in the drafting process, making it unrepresentative.


Husna further explained that some provisions in the draft may cause harm to tobacco farmers, small and medium-sized enterprises, various associations, and the tobacco industry, triggering strong opposition from various parties.


Benguet Saragih, from the Disease Control Working Group at the Ministry of Health, clarified that RPMK 2024 is not aimed at getting people to quit smoking, but rather is intended to prevent children from smoking.


In response, the Chairman of the National Association of Islamic Scholars (PBNU), Miftah Faqih, emphasized that the process of formulating any laws must include a balanced participation from all parties and focus on the common good, otherwise these laws will be ineffective and unfair. The representative of the Ministry of Industry, Nugraha Prasetya Yogi, also stated that the Ministry of Industry was not included in the previous law-making process, which is very detrimental to trade and industry.


Union representative Sudarto pointed out that since the enactment of the 2003 Health Law and Government Regulation No. 28 of 2004, tobacco regulations have gradually been implemented, significantly impacting the tobacco leaf and tobacco products industry. Sudarto emphasized that industrial policies and tax policies have also been used to suppress legal tobacco consumption, leading to the frequent appearance of illegal tobacco products.


Gunawan from the Indonesian Commission for Social Justice and Human Rights (IHCS) is calling for the coordination of existing regulations and laws to protect the interests of tobacco farmers. Indonesian parliament member Muhammad Misbakhun mentioned that the influence of international giants has caused local economies and tobacco farmers to go bankrupt, and therefore calls for the government to be a facilitator in finding a solution to the problem.


Representatives from the Indonesian Tobacco Association, Budiman, believe that restricting the sale of tobacco products will have negative effects on production, employment, and raw material sourcing. Additionally, Kusnasi Mudi, the Secretary General of the National Tobacco Growers Association (APTI), also stated that the government needs to reexamine this regulation and communicate with the entire industry chain to prevent significant impact on the future development of the industry.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
The Bombay High Court has ruled that airport duty-free shops are not exempt from India's domestic regulatory laws merely because they operate beyond the customs barrier, leaving in place a sales halt covering ZYN and FOX nicotine pouches at Mumbai's international airport. The court, however, did not determine that the products necessarily qualify as "drugs" under India's Drugs and Cosmetics Act. The retailers have four weeks to submit product information to the appropriate authorities, including CDSCO, which must complete its review within 30 days of receiving the submissions.
Sep.24
Altria Showcases Ploom, Marlboro Heated Tobacco Sticks and Non-Nicotine Energy Products at NACS Show 2026
Altria Showcases Ploom, Marlboro Heated Tobacco Sticks and Non-Nicotine Energy Products at NACS Show 2026
At the 2026 NACS Show, Altria displayed Ploom devices alongside imagery of Marlboro-branded heated tobacco sticks, while also featuring RIOT Energy and Proper Wild non-nicotine products. The booth showcased on! PLUS nicotine pouches, including 12 mg variants not listed among FDA-authorized products as of October 9, and NJOY e-cigarettes. Altria also presented convenience-store traffic figures highlighting its retail presence. 2Firsts examines the company's expanded product portfolio, non-nicotine business activities and the regulatory status of products displayed at the show.
EXPO
Oct.10
 PMI Opens Generative AI Center in Portugal to Support Global Operations
PMI Opens Generative AI Center in Portugal to Support Global Operations
According to information released by Portugal’s Trade & Investment Agency (AICEP) in July 2026, Philip Morris International (PMI) has established a global Generative Artificial Intelligence Factory (GenAI Factory) at its Portuguese subsidiary Tabaqueira. The center will support PMI’s global operations by developing and deploying AI solutions focused on industrial process optimization, data analytics, operational automation and AI application development. The initiative strengthens Portugal’s role in PMI’s global technology and innovation network.
Aug.27
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Capital is reassessing the global tobacco and modern nicotine industry as heated tobacco, vaping and nicotine pouches reshape demand, profitability and regulation. At the 2026 New Approaches Summit in New York, investors and analysts examined whether smoke-free growth can sustain earnings, how regulation shapes startup value, and whether shareholder engagement can be more effective than divestment. The debate points to a broader shift: tobacco transition is increasingly becoming a capital-allocation, governance and valuation question.
Capital Markets
Oct.05